How neuroinflammation contributes to neurodegeneration
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal lobar dementia are among the most pressing problems of developed societies with aging populations. Neurons carry out essential functions such as signal transmission and network integration in the central nervous system and are the main targets of neurodegenerative disease. In this Review, I address how the neuron’s environment also contributes to neurodegeneration. Maintaining an optimal milieu for neuronal function rests with supportive cells termed glia and the blood-brain barrier. Accumulating evidence suggests that neurodegeneration occurs in part because the environment is affected during disease in a cascade of processes collectively termed neuroinflammation. These observations indicate that therapies targeting glial cells might provide benefit for those afflicted by neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perturbations in immune function have been demonstrated to exacerbate neurodegeneration and metabolic diseases (Lumeng and Saltiel, 2011; Ransohoff, 2016; Reilly and Saltiel, 2017).”
From Deletion of the Alzheimer’s disease risk gene Abi3 locus results in obesity and systemic metabolic disruption in mice (2022) · cites this paper as Ransohoff, 2016
In the citing paper
“This excessive inflammatory response occurs in many neurodegenerative disorders such as Parkinson's (PD) and Alzheimer's diseases (AD) (Ransohoff, 2016),(Perry and Holmes, 2014),(Burguillos et al., 2011),(Abeliovich and Gitler, 2016), as well as in neurological conditions such as ischemic stroke (Lambertsen et al., 2012),(Burguillos et al., 2015).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Ransohoff, 2016
In the citing paper
“Neuroinflammation, a CNS-specific process characterized by proinflammatory cellular and molecular changes to microglia, astrocytes, and the BBB, is considered a core feature of aging and age-related neurological conditions, most notably AD, PD, and ALS (155).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [155]
In the citing paper
“Interestingly, a common feature of PD patients and mouse models is the accumulation of activated microglia and astrocytes, which would promote increased local concentrations of inflammatory mediators and ROS (84).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [84]
In the citing paper
“The notion that neuroinflammatory processes contribute to disease was once provocative, yet recent studies have uncovered multiple mechanisms by which aberrant gliosis causes detrimental neuroinflammation that can influence tau pathology and accelerate neurodegeneration.”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [5]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationHost microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationMicroglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Self-citation
Cited by
Items 601–700 of 1,008
Lopes, J. R. D., Zhang, X., Mayrink, J., Tatematsu, B. K., Guo, L., LeServe, D. S., Abou‐El‐Hassan, H., Rong, F., Dalton, M. J., Oliveira, M. G., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309221120 · Cited by 42
Rafati, N., Zarepour, A., Bigham, A., Khosravi, A., Naderi‐Manesh, H., Iravani, S., & Zarrabi, A. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124800 · Cited by 48
The dual nature of neuroinflammation in networked brain
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1659947 · Cited by 50
Neurotoxicity of Micro- and Nanoplastics: A Comprehensive Review of Central Nervous System Impacts
Ma, Q., Lei, J., Pang, Y., Yu, S., & Zhang, T. (2025) · Environment & Health · doi:10.1021/envhealth.5c00087 · Cited by 54
“64 Neuroinflammation refers to the inflammatory response primarily orchestrated by microglia, astrocytes, and infiltrating peripheral immune cells within the CNS. Animal studies have demonstrated that MNPs can infiltrate microglia or astrocytes and induce their activation, indicating the presence…”
Barbierato, M., Borri, M., Facci, L., Zusso, M., Skaper, S. D., & Giusti, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12529-7 · Cited by 37
Lana, D., Ugolini, F., Nosi, D., Wenk, G. L., & Giovannini, M. G. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00296 · Cited by 40
“Although it is commonly agreed that astroglia is activated and reacts similarly in different conditions (Ransohoff, 2016) and brain areas, our data demonstrate the responses of astrocytes and microglia to aging and LPS-induced inflammation to the same stressful stimuli are different not only among different subregions…”
BackgroundMaternal Overnutrition Programs Central Inflammation and Addiction-Like Behavior in Offspring
Montalvo-Martínez, L., Maldonado‐Ruiz, R., Cárdenas‐Tueme, M., Reséndez‐Pérez, D., & Camacho‐Morales, A. (2018) · BioMed Research International · doi:10.1155/2018/8061389 · Cited by 45
“As mentioned before, neuroinflammation is how the innate immune system protects the CNS and controls initial stimulus, and although it is intended to be protective and beneficial, out-of-control inflammation can be fatal and contribute to tissue damage and disease pathology, including neurodegeneration [73].”
BackgroundSalani, F., Sterbini, V., Sacchinelli, E., Garramone, M., & Bossù, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01768 · Cited by 37
“Aβ plaques are surrounded by activated glial cells releasing inflammatory mediators, hence the sustained neuroinflammatory response has emerged as a third core pathological feature of AD (37), with an acknowledged role in disease pathogenesis and evolution (38, 39).”
BackgroundPhosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease
Morales-Garcia, J. A., Alonso‐Gil, S., Santos, Á., & Pérez‐Castillo, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01745-z · Cited by 38
TLR7/8 in the Pathogenesis of Parkinson’s Disease
Campolo, M., Filippone, A., Biondo, C., Mancuso, G., Casili, G., Lanza, M., Cuzzocrea, S., Esposito, E., & Paterniti, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249384 · Cited by 38
“Neuroinflammation has attracted, for a long time, the attention of scientists due to its potential in developing disease biomarkers and novel therapies [26,27].”
BackgroundNie, Y., Yang, J., Zhou, L., Yang, Z., Liang, J., Liu, Y., Ma, X., Qian, Z., Hong, P., Kalueff, A. V., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02403-3 · Cited by 41
Qiu, M., Zong, J., He, Q., Liu, Y., Wan, Y., Li, M., Zhou, Y., Wu, J., & Hu, B. (2022) · Aging and Disease · doi:10.14336/ad.2022.0212 · Cited by 41
“Additionally, blood cells from patients can be easily obtained and are also suitable for the scRNA-seq analysis [29, 30].”
BackgroundZhang, Y., Zhang, Y., Ye, L., Wu, J., Kang, Y., Zheng, S., & Shao, L. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131750 · Cited by 38
Budgett, R. F., Bakker, G., Sergeev, E., Bennett, K. A., & Bradley, S. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893422 · Cited by 42
“However, there is now accumulating evidence to suggest that neurodegeneration can occur, at least in part, due to neuroinflammation (Ransohoff, 2016).”
BackgroundChen, P., Chen, F., Lei, J., & Zhou, B. (2023) · Phytotherapy Research · doi:10.1002/ptr.7848 · Cited by 42
“It has been demonstrated that inflammation could lead to neuroimmune impairment (Ransohoff, 2016).”
BackgroundThe NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
Palumbo, L., Carinci, M., Guarino, A., Asth, L., Zucchini, S., Missiroli, S., Rimessi, A., Pinton, P., & Giorgi, C. (2023) · Biomedicines · doi:10.3390/biomedicines11102825 · Cited by 41
Miao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 42
“…diseases and pathogens [19]. α-Syn aggregation has been demonstrated to not only evoke the innate immune response but also recruit and activate the adaptive arms of the immune system in PD to promote neuroinflammation [20, 21], and microglial activation is the initial step in this process [22].”
BackgroundThe mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Jin, S., Lü, W., Zhang, J., Zhang, L., Tao, F., Zhang, Y., Hu, X., & Liu, Q. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.09.005 · Cited by 44
Microglia M2A Polarization as Potential Link between Food Allergy and Autism Spectrum Disorders
Kalkman, H. O., & Feuerbach, D. (2017) · Pharmaceuticals · doi:10.3390/ph10040095 · Cited by 38
“This hypothesis was formulated mainly on the basis of results from animal studies; for instance, in mice with a genetic deletion of the chemokine receptor CX3CR3 (a receptor that is exclusively expressed on microglia), which led to delayed synaptic pruning, and ultimately resulted in excessive numbers of immature syna…”
BackgroundLeptin and ghrelin: Sewing metabolism onto neurodegeneration
de Candia, P., & Matarese, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.025 · Cited by 42
Kakae, M., Tobori, S., Morishima, M., Nagayasu, K., Shirakawa, H., & Kaneko, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.055 · Cited by 39
“Dystrophic changes to microglia occur in the aged human brain [7], and recent studies suggest that microglia exhibit regional diversity and sensitivities to aging, with multiple subtypes activated in a variety of CNS diseases [8, 9].”
BackgroundCell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System
Hess, S., & Rambukkana, A. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.bai-0020-2019 · Cited by 44
“Although nerve damage in tuberculoid leprosy is expected to be caused by immunemediated tissue destruction due to strong cell-mediated immune responses (38, 39), it is unknown how multibacillary leprosy with high numbers of bacteria in Schwann cells and minimal or no cell-mediated immune response causes neurological d…”
BackgroundIn Vitro Blood–Brain Barrier-Integrated Neurological Disorder Models Using a Microfluidic Device
Choi, J., Santhosh, M., & Choi, J.-W. (2019) · Micromachines · doi:10.3390/mi11010021 · Cited by 37
“N eu ro in fl am m at io n M od el s Vertical‐aligned neurovascular unit, stimulated with TNF‐α Enable to check the microglia activation against TNF‐α No 3D culture of neural cells Monitoring TEER value and permeability by TNF‐α treatment [93]”
MethodCardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus
Jansson, D., Dieriks, B. V., Rustenhoven, J., Smyth, L. C. D., Scotter, E. L., Aalderink, M., Feng, S. X., Johnson, R. H., Schweder, P. M., Mee, E. T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01787-x · Cited by 38
Jamali-Raeufy, N., Alizadeh, F., Mehrabi, Z., Mehrabi, S., & Goudarzi, M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00715-6 · Cited by 41
“One of hallmarks of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease is inflammation andmicroglial activation (Ransohoff 2016).”
BackgroundCerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder—A Retrospective Chart Review
Campana, M., Strauß, J., Muenz, S., Oviedo-Salcedo, T., Fernando, P., Eichhorn, P., Falkai, P., Hasan, A., & Wagner, E. M. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab105 · Cited by 37
Moradi, F., & Dashti, N. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02196-x · Cited by 40
Yao, Z., Li, J., Bian, L.-H., Li, Q., Wang, X., Yang, X. L., Wei, X.-J., Wan, G., Wang, Y., Shi, J., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7552 · Cited by 38
“Moreover, studies have found that a large amount of α-syn can cause inflammation, while neuroinflammation can further promote α-syn misfolding and damage to dopaminergic neurons, resulting in a vicious cycle of chronic neuroinflammation and neuronal damage throughout PD (Ransohoff, 2016).”
BackgroundZhang, Y., Wei, R., Feng, Y.-Z., Zhang, K.-X., Ge, Y.-J., Kong, X.-Y., Li, X., & Chen, G. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578252 · Cited by 37
Lee, J., Lee, H., Lee, H. G., Shin, M., Shin, M.-G., Seo, J., Lee, E. J., Park, S. A., & Park, S. (2023) · Nature Communications · doi:10.1038/s41467-023-44319-3 · Cited by 42
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
van Wetering, J., Geut, H., Bol, J. G. J. M., Galis, Y., Timmermans, E., Twisk, J. W. R., Hepp, D. H., Morella, M. L., Pihlstrøm, L., Lemstra, A. W., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01786-z · Cited by 48
“Targeting glial cells has been proposed to be beneficial in early-stage neurodegenerative diseases, as neurodegeneration and neuronal cell death are irreversible and are thought to result from chronic neuroinflammation [36–38].”
McLeary, F. A., Davis, A., Rudrawar, S., Perkins, A. V., & Anoopkumar‐Dukie, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.09.034 · Cited by 40
Costa, J., Streich, L., Pinto, S., Pronto‐Laborinho, A. C., Nimtz, M., Conradt, H. S., & de Carvalho, M. A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1482-9 · Cited by 35
The vexing complexity of the amyloidogenic pathway
Castro, M., Hadziselimovic, A., & Sanders, C. R. (2019) · Protein Science · doi:10.1002/pro.3606 · Cited by 43
“While the toxicity of amyloid plaques was once questioned, there now seems to be little question that they are toxic because they trigger chronic inflammation in the brain.(75,76) They also likely serve as a reservoir of toxic Aβ oligomers, which can dissociate from the plaques to re-enter solution.”
BackgroundYin, Y.-L., Guo, R., Shao, Y., Ge, M., Chen, M., Cao, L., Yang, Y., & Hu, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.014 · Cited by 35
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction
Mancini, A., Ghiglieri, V., Parnetti, L., Calabresi, P., & Filippo, M. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.644294 · Cited by 42
Mogavero, M. P., Silvani, A., DelRosso, L. M., Salemi, M., & Ferri, R. (2021) · Cancers · doi:10.3390/cancers13112612 · Cited by 37
Lee, Y., Miller, M. R., Fernandez, M. A., Berg, E. L., Prada, A. M., Ouyang, Q., Schmidt, M., Silverman, J. L., Young-Pearse, T. L., & Morrow, E. M. (2022) · Brain · doi:10.1093/brain/awab467 · Cited by 35
The origin and repopulation of microglia
Zhang, L., Cao, Y., Zhang, X., Gu, X., Mao, Y. Q., & Peng, B. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22862 · Cited by 42
“In fact, the previous “microglia-to-neuron” observation is merely viral leakage and experimental artifacts (Rao et al., 2021), which echoes the observation in the NeuroD1induced astrocyte-to-neuron conversion (Wang et al., 2021).”
BackgroundGao, Y., Hu, M., Niu, X., Li, M., Xu, L., Xiao, Y., Zhang, J., Wang, H., Li, L., Chu, B., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8652741 · Cited by 37
“Inflammation mainly occurs through the activation of microglia and subsequent production of neurotoxic proinflammatory cytokines (PICs), which further induce neuronal damage and even neuronal death, resulting in brain damage [10].”
Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations
Gericke, C., Kirabali, T., Flury, R., Mallone, A., Rickenbach, C., Kulic, L., Toševski, V., Höck, C., Nitsch, R. M., Treyer, V., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13136 · Cited by 36
Tran, S., Kuruppu, S., & Rajapakse, N. W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215231 · Cited by 38
Wang, Y., Jin, J., Wu, G., Wei, W., Jin, Q., & Wang, X. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2313181 · Cited by 41
“…by ROS and the inflammatory stimulation caused by the imbalance of inflammatory factors could initiate or accelerate the neuropathological process (Ransohoff 2016). ω-9 MUFAs exert anti-inflammatory and antioxidant effects through a variety of pathways including intrinsic molecular properties…”
The complex associations between obstructive sleep apnea and auto-immune disorders: A review
Vakil, M., Park, S., & Broder, A. R. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.12.004 · Cited by 38
Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders
Huang, L., Otrokocsi, L., & Sperlágh, B. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.030 · Cited by 37
Andraka, J. M., Sharma, N., & Marchalant, Y. (2019) · Neuroscience Research · doi:10.1016/j.neures.2019.08.001 · Cited by 37
Zhang, X., Zhu, L.-B., He, J., Zhang, H.-Q., Ji, S., Zhang, C., Hou, N.-N., Huang, C.-P., & Zhu, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1712-0 · Cited by 34
Santoni, G., Maggi, F., Amantini, C., Marinelli, O., Nabissi, M., & Morelli, M. B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00251 · Cited by 41
“It is activated by phosphatidylinositol-3,5-biphosphate (PtdIns(3,5)P2), voltage, low pH, and the synthetic compounds MK6-83 and ML-SA1 (Raychowdhury et al., 2004; Dong et al., 2010; Grimm et al., 2010; Shen et al., 2012; Zhang et al., 2012; Chen et al., 2014).”
BackgroundResultInfluentialGuo, X., Rao, Y., Mao, R., Cui, L., & Fang, Y. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108336 · Cited by 38
Senescent accelerated prone 8 (SAMP8) mice as a model of age dependent neuroinflammation
Fernández, A., Quintana, E., Velasco, P., Moreno-Jimenez, B., de Andrés, B., Gaspar, M.-L., Liste, I., Vilar, M., Mira, H., & Cano, E. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02104-3 · Cited by 40
An engineered neurovascular unit for modeling neuroinflammation
Seo, S., Choi, C., Yi, K. S., Kim, S. U., Lee, K., Choi, N., Lee, H. J., Cha, S.-H., & Kim, H. N. (2021) · Biofabrication · doi:10.1088/1758-5090/abf741 · Cited by 39
“Physiologically, microglia and astrocytes are known to release various types of molecules to modulate an acute or chronic inflammatory response [66, 68].”
Lipoxins in the Nervous System: Brighter Prospects for Neuroprotection
Zhang, J., Li, Z., Fan, M., & Jin, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.781889 · Cited by 39
“…appreciated that, in addition to classic infectious diseases such as encephalitis, excessive inflammation also occurs in the pathogenesis of many other neurologicaldiseases including stroke, neurotrauma, and neurodegenerative diseases (Ransohoff, 2016; Devanney et al., 2020; Mészáros et al., 2020).”
Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases
Zahra, W., Birla, H., Singh, S. S., Rathore, A. S., Dilnashin, H., Singh, R., Keshri, P. K., Gautam, P., & Singh, S. P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03591-3 · Cited by 47
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Veiga, M., Azevedo‐Silva, J., & Fernandes, J. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020155 · Cited by 43
“Neuroinflammation is present in pathologies such as multiple sclerosis, ischemia, and AD [107].”
BackgroundKopeć, K., Szleszkowski, S., Koziorowski, D., & Szlufik, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210366 · Cited by 42
Foucault‐Fruchard, L., Doméné, A., Page, G., Windsor, M., Emond, P., Rodrigues, N., Dollé, F., Damont, A., Buron, F., Routier, S., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.019 · Cited by 39
Chu, M., Wen, L., Jiang, D., Liu, L., Nan, H., Yue, A., Wang, Y., Wang, Y., Qu, M., Wang, N., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02746-5 · Cited by 33
“Several studies that include animal models [3–5], human fluid biomarkers [6–8], or brain tissue immunohistochemistry [9–11] have provided evidence that an ongoing inflammatory process is involved in the progression of sporadic or genetic FTD, manifesting as microglial activation/dystrophy, astrogliosis, and increased…”
BackgroundGenetically modified non-human primate models for research on neurodegenerative diseases
Pan, M.-T., 暨南大学粤港澳中枢神经再生研究院, 广., Zhang, H., Li, X., & Guo, X. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.197 · Cited by 41
“…advancements in medical technologies and the increasing global population, NDs are expected to impose an intense burden on the medical system and affected families, both economically and emotionally, in the coming decades (Labzin et al., 2018; Rai et al., 2022; Ransohoff, 2016; Wyss-Coray, 2016).”
BackgroundDUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Qin, B., Chen, X., Wang, F., & Wang, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02237-3 · Cited by 37
Chen, L., Luo, S., Liu, T., Shuai, Z., Song, Y., Yang, Q., Wang, Y., Huang, H., & Luo, Y. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03369-8 · Cited by 39
“When microglia become activated, they undergo alterations in shape and gene expression, along with heightened antigen display, engulfment of debris, and the secretion of pro-inflammatory molecules and chemokines [8, 12].”
Esculentoside A exerts anti-inflammatory activity in microglial cells
Yang, H., Chen, Y., Yu, L., & Xu, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.014 · Cited by 35
Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells
Sharma, M., Arbabzada, N., & Flood, P. M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.017 · Cited by 35
The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
Khadka, B., Lee, J., Park, D. H., Kim, K.-T., & Bae, J. (2020) · Biomolecules · doi:10.3390/biom10101401 · Cited by 36
Feng, H., Liu, Y., Zhang, R., Liang, Y., Sun, L., Lan, N., & Ma, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.544431 · Cited by 36
“Recent research suggests that the development of neuroinflammation is closely related to a variety of neurodegenerative diseases (Ransohoff, 2016).”
BackgroundWhat, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
Przybył, Ł., Woźna, M., Kozłowska, E., & Fiszer, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041561 · Cited by 34
“For a broader group of neurodegenerative diseases, some common changes can be observed due to neuroinflammation [9].”
BackgroundKeuters, M. H., Keksa-Goldsteine, V., Dhungana, H., Huuskonen, M. T., Pomeshchik, Y., Savchenko, E., Korhonen, P., Singh, Y., Wojciechowski, S., Lehtonen, Š., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81741-3 · Cited by 34
Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
Lee, S. Y. H., Yates, N. J., & Tye, S. J. (2021) · The Neuroscientist · doi:10.1177/1073858421992265 · Cited by 37
The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
Ferri, E., Rossi, P. D., Geraci, A., Ciccone, S., Cesari, M., & Arosio, B. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627931 · Cited by 41
“It has been demonstrated that β-amyloid (Aβ) can activate microglia cells and initiate the chronic inflammatory response (at least, partially) responsible for neurodegeneration (Mosher and WyssCoray, 2014; Heneka et al., 2015; Ransohoff, 2016).”
BackgroundParkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
Gundersen, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580311 · Cited by 33
Arbo, B. D., Schimith, L. E., dos Santos, M. G., & Hort, M. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174800 · Cited by 34
Nam, H., Lee, Y., Kim, B., Lee, J.-W., Hwang, S., An, H., Chung, K. M., Park, Y., Hong, J., Kim, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29653-2 · Cited by 36
Sui, S. X., Balanta‐Melo, J., Pasco, J. A., & Plotkin, L. I. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00736-9 · Cited by 43
Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders
Jůza, R., Musílek, K., Mezeiová, E., Soukup, O., & Korábečný, J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21923 · Cited by 37
The therapeutic potential of triptolide and celastrol in neurological diseases
Cui, Y., Jiang, X., & Feng, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1024955 · Cited by 39
“However, studies have shown that neuroinflammation is involved in the development of neurological diseases and that excessive neuroinflammation exacerbates the severity of the diseases (Ransohoff, 2016).”
BackgroundLiu, X., Cheng, Z.-Y., Li, Y.-F., Liu, C., Wang, C., Gong, X., & He, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175443 · Cited by 34
Mahaman, Y. A. R., Huang, F., Salissou, M. T. M., Yacouba, M. B. M., Wang, J., Liu, R., Zhang, B., Li, H., Zhu, F., & Wang, X. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01356-6 · Cited by 35
The role of trained immunity in sepsis
Wang, W., Ma, L., Liu, B., & Ouyang, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1449986 · Cited by 43
Constitutive DAMPs in CNS injury: From preclinical insights to clinical perspectives
Castellanos-Molina, A., Bretheau, F., Boisvert, A., Bélanger, D., & Lacroix, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.047 · Cited by 47
“However, despite the existence of these borders, it is now acknowledged that various events may trigger disastrous sterile inflammatory responses in the injured CNS (Ransohoff, 2016; Salvador and Kipnis, 2022).”
Jiang, C., Caskurlu, A., Ganesh, T., & Dingledine, R. J. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100132 · Cited by 37
“It has been proposed that neuroinflammation contributes to neurodegeneration (Ransohoff, 2016), but in our studies LPS caused no neurodegeneration although it did reduce the levels of pre- and postsynaptic proteins in cortex.”
BackgroundWeerasekera, A., Morrissey, E. J., Kim, M., Saha, A., Lin, Y., Alshelh, Z., Torrado-Carvajal, Á., Albrecht, D., Akeju, O., Kwon, Y., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002198 · Cited by 37
Kular, L., Ewing, E., Needhamsen, M., Kakhki, M. P., Covacu, R., Gómez-Cabrero, D., Brundin, L., & Jagodic, M. (2022) · Epigenetics · doi:10.1080/15592294.2021.2020436 · Cited by 32
“The study of glial cell populations has gained particular interest due to the possibility to decipher the neurotoxic and pro-inflammatory processes precipitating neuronal vulnerability in progressive MS and thereby, to ultimately restore the brain repair capacities favouring remyelination and neuroprotection [8].”
BackgroundBoosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 37
“The complexity of selective vulnerabilities (Fu et al., 2018), protein aggregation (Spires-Jones et al., 2017), inflammation (Ransohoff, 2016), mitochondrial dysfunctions (Monzio Compagnoni et al., 2020) and specific other deficits in energy metabolism (Murphy and Hartley, 2018) have been reviewed…”
BackgroundFathi, M., Vakili, K. G., Yaghoobpoor, S., Qadirifard, M. S., Kosari, M., Naghsh, N., Taei, A. A., Klegeris, A., Dehghani, M., Bahrami, A., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.855776 · Cited by 41
“Microglial activation leads to the secretion of various proinflammatory mediators, including interleukin (IL) 1β, IL6, and tumor necrosis factor α (TNF-α), to restore tissue hemostasis and also facilitate tissue repair (Ransohoff and Brown, 2012; Ransohoff, 2016; Molteni and Rossetti, 2017).”
BackgroundThe roles of fungus in CNS autoimmune and neurodegeneration disorders
Wu, C., Jiang, M., Jiang, R., Pang, T., & Zhang, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1077335 · Cited by 34
“This progressive loss of neurons is also associated with the release of the misfolded and aggregated protein a-synuclein (aSyn), which is expressed primarily in neurons throughout the brain (99).”
BackgroundHsiao, G., Chi, W.-C., Pang, K.-L., Chen, J., Kuo, Y., Wang, Y.-K., Cha, H.-J., Chou, S.-C., & Lee, T. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00196 · Cited by 32
The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease
Qureshi, Y. H., Berman, D. E., Marsh, S. E., Klein, R. L., Patel, V. M., Simoes, S., Kannan, S., Petsko, G. A., Stevens, B., & Small, S. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110262 · Cited by 31
Zhang, L., Xu, F., Yang, Y., Yang, L., Wu, Q., Sun, H., An, Z., Li, J., Wu, H., Song, J., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116386 · Cited by 34
Yang, R., Wang, R., Xu, A., Zhang, J., & Ma, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1425731 · Cited by 41
“In MS, microglia are not the primary triggers but are in fl uenced by a wider immune disturbance (Ransohoff, 2016).”
Neurodegenerative diseases and neuroinflammation-induced apoptosis
Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1051 · Cited by 39
Kang, S., Ughetta, M. E., Zhang, J. Y., Marallano, V. J., Sattiraju, A., Hannah, T., Wahane, S., Ramakrishnan, A., Estill, M. S., Tsankova, N. M., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00985-4 · Cited by 40
“Upon pathological stimuli, MG rapidly alter morphology and transcriptional profiles 8 .”
Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration
Hussain, M. S., Agrawal, N., Ilma, B., Rekha, M. M., Nayak, P. P., Kaur, M., Khachi, A., Goyal, K., Rekha, A., Gupta, S., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70503 · Cited by 37
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome
Raha-Chowdhury, R., Henderson, J. W., Raha, A. A., Stott, S. R. W., Vuono, R., Foscarin, S., Wilson, L., Annus, T., Fincham, R., Allinson, K., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170814 · Cited by 31
“Although dysfunction of amyloid- protein precursor (A PP) processing is believed to be the key upstream factor in the pathogenesis of AD [6], neuroinflammation and activation of innate immunity are considered early events in the genesis of a variety of neurodegenerative diseases [7, 8].”
BackgroundThrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders
Festoff, B. W., & Citron, B. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00059 · Cited by 34
“In addition to these cellular characteristics, neuroinflammation includes humoral features such as proinflammatory cytokine and chemokine overproduction, along with their respective receptors (151).”
BackgroundSeguella, L., Capuano, R., Sarnelli, G., & Esposito, G. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1612744 · Cited by 35
“Based on this evidence, several studies have shown how inhibiting reactive gliosis and restoring astrocytes functions, could be a fascinating way to promote neuroprotection and arrest the progression of a variety of brain disorders [39].”
BackgroundPhosphorylation and Dephosphorylation of Tau Protein During Synthetic Torpor
Luppi, M., Hitrec, T., Cristoforo, A. D., Squarcio, F., Stanzani, A., Occhinegro, A., Chiavetta, P., Tupone, D., Zamboni, G., Amici, R., et al. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00057 · Cited by 36
“It is known that microgliosis, a crucial step in neuroinflammation that is characterized by an activation and proliferation of microglia, is an important hallmark of tauopathies (Ransohoff, 2016; Nilson et al., 2017).”
BackgroundCorreia, S. S., Liu, G., Jacobson, S., Bernier, S. G., Tobin, J. V., Schwartzkopf, C. D., Atwater, E., Lonie, E., Rivers, S., Carvalho, A., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02275-z · Cited by 33
“Background Neurodegenerative diseases are complex and heterogenous, and yet chronic neuroinflammation is a core facet across diseases [1].”
BackgroundHypothalamic microinflammation
Cai, D., & Khor, S. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820683-6.00023-3 · Cited by 34
Ossola, B., Rifat, A., Rowland, A., Hunter, H., Drinkall, S., Bender, C., Hamlischer, M., Teall, M. R., Burley, R., Barker, D. F., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109330 · Cited by 30
“Many of these genes are exclusively expressed in microglia indicating a key role of this cell type in neuroinflammation and pathogenic disease processes (Colonna and Butovsky, 2017; Ransohoff, 2016).”
BackgroundLi, Z., Zhao, T., Shi, M., Wei, Y., Huang, X., Shen, J., Zhang, X., Xie, Z., Huang, P., Yuan, K., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1139558 · Cited by 36
Conte, C., Ingrassia, A. M. T., Brevé, J. J. P., Bol, J. G. J. M., Huisman, E., van Dam, A., Beccari, T., & van de Berg, W. D. J. (2023) · Cells · doi:10.3390/cells12101368 · Cited by 36
Metadata
- Authors
- Ransohoff, R. M.
- Affiliations
- Biogen (United States) (US)
- Corresponding author
- Ransohoff, Richard M.
- Venue
- Science
- Published
- 2016-08-19
- Volume
- 353
- Issue
- 6301
- Pages
- 777-783
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2517534055
- Semantic Scholar
- bfcfccbbc79f79cab04ba4617a0680c58ddb26a2
- Cited by
- 1,967
- References
- 87
- Citations by year
- 2026: 178 · 2025: 182 · 2024: 191 · 2023: 197 · 2022: 241 · 2021: 262 · 2020: 213 · 2019: 192 · 2018: 166 · 2017: 130 · 2016: 11
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- neuroinflammation, neurodegeneration, glial cells, blood-brain barrier, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal lobar dementia
- MeSH terms
- CX3C Chemokine Receptor 1, Blood-Brain Barrier, Humans, Inflammation, Membrane Glycoproteins, Neurons, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Receptors, Chemokine, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.